MaximBio and Thomas Scientific Ink Marketing Agreement for ClearDetectTM COVID-19 Antigen Home Test

Rockville, MarylandAnd January 27 2022 /PRNewswire/ – Today, Maxim Biomedical (MaximBio), a leading healthcare diagnostics company and manufacturer of trusted diagnostic solutions, announced a comprehensive marketing and distribution agreement with Thomas Scientific for ClearDetectTM COVID-19 home test (ClearDetectTM) that received an Emergency Use Authorization (EUA) from the US Food and Drug Administration on Jan 19 2022.

MaximBio ClearDetect COVID-19 Antigen Home Test 2-Test Pack

MaximBio ClearDetect COVID-19 Antigen Home Test 2-Test Pack

When asked about cooperation, Anthony MorrisonMaximBio’s Chief Commercial Officer said: “Their dedication to providing the best products with personalized and efficient service makes them an ideal partner for MaximBio as we work together to help meet the growing demand for COVID-19 testing.” Michael Brown, Senior Vice President of Clinical Diagnostics at Thomas Scientific, agreed: “For more than a century, Thomas Scientific has been committed to providing high-quality laboratory products while meeting the unique needs of individual customers. We are excited to add the innovative MaximBio test to our product offering.”

the ClearDetectTM COVID-19 home test It uses proven LFA technology with a simplified workflow that can be easily performed at home without the need for equipment or a reader. The unique test format includes only 3 components – a swab, test strip and test tube pre-filled with sample buffer. This eliminates reagent metering or the need to handle dropper bottles as required with other card-based and self-test systems.

When compared to a PCR method authorized by the EUA, the . file Maximbio ClearDetectTM COVID-19 home test It performed well, achieving 86.9% positive agreement (PPA) and 98.9% negative agreement (NPA), making it one of the most sensitive and specific antigen tests available. The test also performed admirably when evaluated by the National Institutes of Health with samples positive for the Omicron variant, revealing 100% of live Omicron samples diluted to a PCR Ct value of 25.8. In the same study, the assay detected an Omicron variant at a higher dilution than two other EUA-approved antigen tests.

The test will be available in two batch configurations – two (2) boxed tests for convenient use at home, and in a bundled package of 25 tests adaptable to healthcare settings, schools, workplaces, and other high-volume test scenarios. Thomas Scientific will market both configurations and plans to price them competitively. MaximBio is currently ramping up production to meet the demand for COVID-19 testing and Thomas Scientific’s desire to meet customer needs.

About Maxim Biomedical Inc.
Headquartered in Rockville, MDMaxim Biomedical is a leading diagnostic healthcare company that provides innovative solutions by developing and manufacturing reliable testing solutions. Our mission is to create affordable and accessible diagnostic products and enable actionable testing to improve patient outcomes around the world.

For more information visit maximbio.com

About Thomas Scientific
Founded in 1900, Thomas Scientific provides state-of-the-art supplies, equipment, and supply chain solutions to the scientific community – supporting all laboratory research, biopharmaceuticals, medical devices, clinical diagnostics, cleanrooms, and other related end markets. In accordance with our mission to be the most trusted partner in science for our customers, suppliers and partners, we offer one-to-one service and a comprehensive product portfolio at competitive prices, along with customized supply chain service solutions. Whether you work in a lab or controlled environment, or do your testing in the field, Thomas Scientific has the products you need.

Maxim Biomedical (PRNewsfoto/Maxim Biomedical, Inc.)

Maxim Biomedical (PRNewsfoto/Maxim Biomedical, Inc.)

Cision

Cision

Show original content for multimedia download: 301469993.html

SOURCE Maxim Biomedical, Inc.

Leave a Comment